^
CANCER:
Fallopian Tube Cancer
BRCA1 mutation
Fallopian Tube Cancer
BGB-290
Sensitive
:
A1
BeiGene Press Release - 4d
BRCA2 mutation
Fallopian Tube Cancer
BGB-290
Sensitive
:
A1
BeiGene Press Release - 4d
No biomarker
Fallopian Tube Cancer
bevacizumab + olaparib
Sensitive
:
A2
NICE - 1wk
HRD
Fallopian Tube Cancer
bevacizumab + olaparib
Sensitive
:
A1
NICE - 1wk
No biomarker
Fallopian Tube Cancer
niraparib
Sensitive
:
A1
No biomarker
Fallopian Tube Cancer
bevacizumab
Sensitive
:
A1
No biomarker
Fallopian Tube Cancer
Mvasi (bevacizumab biosimilar)
Sensitive
:
A1
No biomarker
Fallopian Tube Cancer
Aybintio (bevacizumab biosimilar)
Sensitive
:
A1
No biomarker
Fallopian Tube Cancer
Onbevzi (bevacizumab biosimilar)
Sensitive
:
A1
BRCA1 mutation
Fallopian Tube Cancer
rucaparib
Sensitive
:
A1
BRCA2 mutation
Fallopian Tube Cancer
rucaparib
Sensitive
:
A1
No biomarker
Fallopian Tube Cancer
rucaparib
Sensitive
:
A1
BRCA2 mutation
Fallopian Tube Cancer
bevacizumab + olaparib
Sensitive
:
A1
BRCA1 mutation
Fallopian Tube Cancer
bevacizumab + olaparib
Sensitive
:
A1
No biomarker
Fallopian Tube Cancer
olaparib
Sensitive
:
A1
BRCA1 mutation
Fallopian Tube Cancer
niraparib
Sensitive
:
A1
BRCA2 mutation
Fallopian Tube Cancer
niraparib
Sensitive
:
A1
HRD
Fallopian Tube Cancer
niraparib
Sensitive
:
A1
BRCA2 mutation
Fallopian Tube Cancer
olaparib
Sensitive
:
A1
BRCA1 mutation
Fallopian Tube Cancer
olaparib
Sensitive
:
A1
No biomarker
Fallopian Tube Cancer
carboplatin + micellar paclitaxel
Sensitive
:
A1
No biomarker
Fallopian Tube Cancer
Bevax (bevacizumab biosimilar)
Sensitive
:
A1
No biomarker
Fallopian Tube Cancer
CAPOX
Sensitive
:
A2
No biomarker
Fallopian Tube Cancer
sorafenib
Sensitive
:
A2
No biomarker
Fallopian Tube Cancer
topotecan
Sensitive
:
A2
No biomarker
Fallopian Tube Cancer
pegylated liposomal doxorubicin
Sensitive
:
A2
MSI-H/dMMR
Fallopian Tube Cancer
pembrolizumab
Sensitive
:
A2
NTRK3 fusion
Fallopian Tube Cancer
larotrectinib
Sensitive
:
A2
VERI is free for non-commercial use, no login needed.
Content on this site is for research purposes only and is not intended  to be a substitute for medical advice.
For commercial access, including additional premium features, please contact us.
By using VERI, you are agreeing to our